India’s generic pharmaceutical producers face numerous challenges after the country’s patent law was amended to make it compatible with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Two amendments were significant:...
CITATION STYLE
Dhar, B., & Joseph, R. K. (2019). The Challenges, Opportunities and Performance of the Indian Pharmaceutical Industry Post-TRIPS (pp. 299–323). https://doi.org/10.1007/978-981-13-8102-7_13
Mendeley helps you to discover research relevant for your work.